Here's why Australia and New Zealand Banking Group shares have plunged 10%

Australia and New Zealand Banking Group (ASX:ANZ) shares have fallen 10% in the past month despite booking a profit rise earlier this week.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a very tough week for big bank shareholders…

Every one of the Big Four banks have fallen hard. The worst, Commonwealth Bank of Australia (ASX: CBA), is down more than 7.1%.

Whilst only falling 2.8% this week, shares of Australia and New Zealand Banking Group (ASX: ANZ) are down a whopping 10.5% in the past month alone.

Following Westpac Banking Corp's (ASX: WBC) poor results on Monday and National Australia Bank Ltd's (ASX: NAB) hard-to-swallow profit figures this morning, ANZ is actually the only big bank to have reported decent results.

However, they weren't great results by any means.

…and when a stock is trading at a very rich valuation, like ANZ is, investors can sometimes be merciless in selling it down.

Indeed although ANZ's headline profit figure was slightly ahead of expectations, there are signs the good times could be coming to an end.

Firstly dividend growth was below expectations.

The bank's net interest margin (a key measure of profitability) fell meaningfully lower to 2.04%, from 2.15% a year earlier.

Return on equity fell from 15.5% to 14.7%. Return on assets also fell.

Meanwhile, the bank's operating expense ratio jumped to 45.1% from 44.3%.

Then there was the bank's outlook, which said the future will be characterised by a "lower growth environment."

Should you buy ANZ shares?

Now is not the time to buy ANZ shares. Despite its share price falling 10% this past month there are a number of headwinds which lay ahead of our big banks and with share prices in many of them still quite expensive, they may yet fall further.

Motley Fool contributor Owen Raskiewicz has no position in any stocks mentioned. Owen welcomes your feedback on Google plus (see below) or you can follow him on Twitter @ASXinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »